Rezultati pretraživanja
  1. 1. lip 2019.
    Odgovor korisnicima i sljedećem broju korisnika:

    Yes., always ask the patient. In an excellent study presented at found that Half of older patients with cancer rated other outcomes (particularly cognitive ability) as being more important than survival.

  2. 1. svi 2019.

    During Annual Mtg, >17.5K Twitter users sent >80K tweets. Participate this Annual Mtg using . Use the standard hashtags in the pic & check out the social media guide for tips!

  3. 11. velj 2019.

    peg-IL2 + PD1 combo in bladder cancer data abstract out for ASCO ORR dropped to 48% (11/23) from 60% (6/10) at

  4. 3. lip 2019.

    Dr. ’s presentation on assoc btwn use of professional title & race/gender of introducer & speaker was excellent. Thousands of videos reviewed & coded from & Annual mtgs. A labor of love, nicely done. cc – mjesto: McCormick Place

  5. 3. lip 2019.

    EGFR exon 20 mutations: an urgent medical need. TAK-788 efficacy and safety. Small numbers but it’s way better than historic EGFR TKIs. ORR 43% PFS 7.9. Without brain mets: ORR 56% PFS 8.1. Most relevant toxicity: GI. Presented by

  6. 31. svi 2019.

    This is special for sev reasons, above all b/c my grandma (& last grandparent) died hrs before I spoke at . I showed her photo to end my talk. A bittersweet mtg. Now my grandpa is in slides. Neither was in medicine. They would never believe it. 🙏

  7. 3. lip 2019.

    No role for adjuvant VEGFR TKI following metastasectomy in mRCC by L Appleman confirming RESORT - waiting for IO in this space!

  8. 4. stu 2019.
    Odgovor korisnicima

    Yes - good PS + continued afebrile status, good PO intake, excellent family support and home-to-hospital proximity were all key factors in this “record” run - everything has to go right for this to even be considered. had an abstract

  9. 29. svi 2019.

    ⏪Flashback to when spoke on the promising therapies, both approved and coming through, in . We are interested 💭 in the acute myeloid leukemia advances being discussed during , are you?

  10. 30. sij

    Reportable actionability versus pragmatic actionability: Implementing at three large health systems. et al. Abstract 6539

  11. 30. sij

    Successful automated normalization of cancer outcomes for half a million patients across four disparate health systems. Tittel et al. Abstract e18763

  12. 11. lis 2019.

    🤯Mind blowing that this happens in 2017-2018 Excellent job by et al highlighting in speaker introductions at & Should address ALL physicians as Dr. Link:

  13. Congratulations to our colleagues for publishing in the results of the trial presented at : more evidence on the role of adding to in premenopausal patients

  14. 17. srp 2019.
    Odgovor korisniku/ci

    Osi showed activity in rare muts. There was a presentation about a phase II at with 36 pts with ORR 50% but PFS 9.5 months. I personally would consider chemo +gef. In ’s study 60 pts x arm with Exon 21 mut and experimental arm did a lot better.

  15. 21. lip 2019.
    Odgovor korisnicima i sljedećem broju korisnika:

    I never lost an opportunity to have a selfie with the superstar (this picture below is from Unfortunately I’m not going to to have a new selfie - but certainly will be following on :-)

  16. 18. lip 2019.
    Odgovor korisnicima

    A5. Results presented at showed great response to mFOLFIRINOX in pts after surgery (); guidelines were recently updated to include this recommendation.

  17. Odgovor korisniku/ci

    Thank you very much, very kind to share the slide! Hope these data are helpful for our young patients...and looking forward to seeing the publication of the important study by Dr. Poorvu ( group) presented at

  18. Odgovor korisnicima i sljedećem broju korisnika:

    I attended on a grant specifically to live tweet for . At I cut back on live tweeting because I missed too much while trying to translate findings into 140 char. I did not attend or due to cost and too much June travel.

  19. The trial presented at just published in : shorter duration of can be considered an option for selected patients with -positive early

  20. 5. lip 2019.

    Duma et al (Abstr 10503) Just stunning - Female speakers @ & were 6x more likely to be introduced only by 1st name, not professional title, than males. And black speakers rec'd proper professional address 31% vs. 73% for whites

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.